QSS
FPRX

Quantitative Systematic Strategies’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quantitative Systematic Strategies’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19,113
Closed -$325K – 814
2020
Q4 		$325K Buy
+19,113
New +$239K 0.05% 467
2016
Q1 		– Sell
-7,858
Closed -$327K – 877
2015
Q4 		$327K Sell
7,858
-17,500
-69% -$587K 0.09% 303
2015
Q3 		$390K Buy
+25,358
New +$545K 0.19% 226

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Quantitative Systematic Strategies's FPRX Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 19,113 shares — an estimated $325K sold.

Quantitative Systematic Strategies first reported a position in FPRX in Q3 2015 and held it in 3 quarters. The position peaked at $390K in Q3 2015. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 19,113 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $325K.
  • Quantitative Systematic Strategies first reported a position in Five Prime Therapeutics, Inc. in Q3 2015 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Five Prime Therapeutics, Inc. position peaked at $390K in Q3 2015.
  • 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.